| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |